 | • レポートコード：MRC2-11QY11505 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、125ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は臍帯血幹細胞のグローバル市場について調査・分析したレポートです。種類別（同種幹細胞、自家幹細胞）市場規模、用途別（自己免疫疾患、免疫不全、悪性腫瘍、癌、固形腫瘍、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別臍帯血幹細胞の競争状況、市場シェア ・世界の臍帯血幹細胞市場：種類別市場規模 2015年-2020年（同種幹細胞、自家幹細胞） ・世界の臍帯血幹細胞市場：種類別市場規模予測 2021年-2026年（同種幹細胞、自家幹細胞） ・世界の臍帯血幹細胞市場：用途別市場規模 2015年-2020年（自己免疫疾患、免疫不全、悪性腫瘍、癌、固形腫瘍、その他） ・世界の臍帯血幹細胞市場：用途別市場規模予測 2021年-2026年（自己免疫疾患、免疫不全、悪性腫瘍、癌、固形腫瘍、その他） ・北米の臍帯血幹細胞市場分析：米国、カナダ ・ヨーロッパの臍帯血幹細胞市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの臍帯血幹細胞市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の臍帯血幹細胞市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの臍帯血幹細胞市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Advanced Cell Technology、California Stem Cell、Cytori Therapeutics、Mesoblast Limited、Opexa Therapeutics Inc.、Athersys Inc.、Geron Corporation、Neostem Inc.、CBR Systems, Inc.、Cordlife、Cryo-Cell、Cryo-Save AG (A Group of Esperite)、Lifecell、Stemcyte、Viacord、Smart Cells International Ltd.、Cryoviva India、Cordvida、China Cord Blood Corporation ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Cord Blood Stem Cells Market
The global Cord Blood Stem Cells market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Cord Blood Stem Cells Scope and Market Size
Cord Blood Stem Cells market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cord Blood Stem Cells market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Advanced Cell Technology
California Stem Cell
Cytori Therapeutics
Mesoblast Limited
Opexa Therapeutics Inc.
Athersys Inc.
Geron Corporation
Neostem Inc.
CBR Systems, Inc.
Cordlife
Cryo-Cell
Cryo-Save AG (A Group of Esperite)
Lifecell
Stemcyte
Viacord
Smart Cells International Ltd.
Cryoviva India
Cordvida
China Cord Blood Corporation
Market segment by Type, the product can be split into
Allogeneic Stem Cell
Autologous Stem Cell
Market segment by Application, split into
Autoimmune Diseases
Immunodeficiencies
Malignancies,Caners
Solid Tumors
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cord Blood Stem Cells Revenue
1.4 Market by Type
1.4.1 Global Cord Blood Stem Cells Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Allogeneic Stem Cell
1.4.3 Autologous Stem Cell
1.5 Market by Application
1.5.1 Global Cord Blood Stem Cells Market Share by Application: 2020 VS 2026
1.5.2 Autoimmune Diseases
1.5.3 Immunodeficiencies
1.5.4 Malignancies,Caners
1.5.5 Solid Tumors
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Cord Blood Stem Cells Market Perspective (2015-2026)
2.2 Global Cord Blood Stem Cells Growth Trends by Regions
2.2.1 Cord Blood Stem Cells Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Cord Blood Stem Cells Historic Market Share by Regions (2015-2020)
2.2.3 Cord Blood Stem Cells Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Cord Blood Stem Cells Market Growth Strategy
2.3.6 Primary Interviews with Key Cord Blood Stem Cells Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Cord Blood Stem Cells Players by Market Size
3.1.1 Global Top Cord Blood Stem Cells Players by Revenue (2015-2020)
3.1.2 Global Cord Blood Stem Cells Revenue Market Share by Players (2015-2020)
3.1.3 Global Cord Blood Stem Cells Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cord Blood Stem Cells Market Concentration Ratio
3.2.1 Global Cord Blood Stem Cells Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Cord Blood Stem Cells Revenue in 2019
3.3 Cord Blood Stem Cells Key Players Head office and Area Served
3.4 Key Players Cord Blood Stem Cells Product Solution and Service
3.5 Date of Enter into Cord Blood Stem Cells Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Cord Blood Stem Cells Historic Market Size by Type (2015-2020)
4.2 Global Cord Blood Stem Cells Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Cord Blood Stem Cells Market Size by Application (2015-2020)
5.2 Global Cord Blood Stem Cells Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Cord Blood Stem Cells Market Size (2015-2020)
6.2 Cord Blood Stem Cells Key Players in North America (2019-2020)
6.3 North America Cord Blood Stem Cells Market Size by Type (2015-2020)
6.4 North America Cord Blood Stem Cells Market Size by Application (2015-2020)
7 Europe
7.1 Europe Cord Blood Stem Cells Market Size (2015-2020)
7.2 Cord Blood Stem Cells Key Players in Europe (2019-2020)
7.3 Europe Cord Blood Stem Cells Market Size by Type (2015-2020)
7.4 Europe Cord Blood Stem Cells Market Size by Application (2015-2020)
8 China
8.1 China Cord Blood Stem Cells Market Size (2015-2020)
8.2 Cord Blood Stem Cells Key Players in China (2019-2020)
8.3 China Cord Blood Stem Cells Market Size by Type (2015-2020)
8.4 China Cord Blood Stem Cells Market Size by Application (2015-2020)
9 Japan
9.1 Japan Cord Blood Stem Cells Market Size (2015-2020)
9.2 Cord Blood Stem Cells Key Players in Japan (2019-2020)
9.3 Japan Cord Blood Stem Cells Market Size by Type (2015-2020)
9.4 Japan Cord Blood Stem Cells Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Cord Blood Stem Cells Market Size (2015-2020)
10.2 Cord Blood Stem Cells Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cord Blood Stem Cells Market Size by Type (2015-2020)
10.4 Southeast Asia Cord Blood Stem Cells Market Size by Application (2015-2020)
11 India
11.1 India Cord Blood Stem Cells Market Size (2015-2020)
11.2 Cord Blood Stem Cells Key Players in India (2019-2020)
11.3 India Cord Blood Stem Cells Market Size by Type (2015-2020)
11.4 India Cord Blood Stem Cells Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Cord Blood Stem Cells Market Size (2015-2020)
12.2 Cord Blood Stem Cells Key Players in Central & South America (2019-2020)
12.3 Central & South America Cord Blood Stem Cells Market Size by Type (2015-2020)
12.4 Central & South America Cord Blood Stem Cells Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Advanced Cell Technology
13.1.1 Advanced Cell Technology Company Details
13.1.2 Advanced Cell Technology Business Overview
13.1.3 Advanced Cell Technology Cord Blood Stem Cells Introduction
13.1.4 Advanced Cell Technology Revenue in Cord Blood Stem Cells Business (2015-2020))
13.1.5 Advanced Cell Technology Recent Development
13.2 California Stem Cell
13.2.1 California Stem Cell Company Details
13.2.2 California Stem Cell Business Overview
13.2.3 California Stem Cell Cord Blood Stem Cells Introduction
13.2.4 California Stem Cell Revenue in Cord Blood Stem Cells Business (2015-2020)
13.2.5 California Stem Cell Recent Development
13.3 Cytori Therapeutics
13.3.1 Cytori Therapeutics Company Details
13.3.2 Cytori Therapeutics Business Overview
13.3.3 Cytori Therapeutics Cord Blood Stem Cells Introduction
13.3.4 Cytori Therapeutics Revenue in Cord Blood Stem Cells Business (2015-2020)
13.3.5 Cytori Therapeutics Recent Development
13.4 Mesoblast Limited
13.4.1 Mesoblast Limited Company Details
13.4.2 Mesoblast Limited Business Overview
13.4.3 Mesoblast Limited Cord Blood Stem Cells Introduction
13.4.4 Mesoblast Limited Revenue in Cord Blood Stem Cells Business (2015-2020)
13.4.5 Mesoblast Limited Recent Development
13.5 Opexa Therapeutics Inc.
13.5.1 Opexa Therapeutics Inc. Company Details
13.5.2 Opexa Therapeutics Inc. Business Overview
13.5.3 Opexa Therapeutics Inc. Cord Blood Stem Cells Introduction
13.5.4 Opexa Therapeutics Inc. Revenue in Cord Blood Stem Cells Business (2015-2020)
13.5.5 Opexa Therapeutics Inc. Recent Development
13.6 Athersys Inc.
13.6.1 Athersys Inc. Company Details
13.6.2 Athersys Inc. Business Overview
13.6.3 Athersys Inc. Cord Blood Stem Cells Introduction
13.6.4 Athersys Inc. Revenue in Cord Blood Stem Cells Business (2015-2020)
13.6.5 Athersys Inc. Recent Development
13.7 Geron Corporation
13.7.1 Geron Corporation Company Details
13.7.2 Geron Corporation Business Overview
13.7.3 Geron Corporation Cord Blood Stem Cells Introduction
13.7.4 Geron Corporation Revenue in Cord Blood Stem Cells Business (2015-2020)
13.7.5 Geron Corporation Recent Development
13.8 Neostem Inc.
13.8.1 Neostem Inc. Company Details
13.8.2 Neostem Inc. Business Overview
13.8.3 Neostem Inc. Cord Blood Stem Cells Introduction
13.8.4 Neostem Inc. Revenue in Cord Blood Stem Cells Business (2015-2020)
13.8.5 Neostem Inc. Recent Development
13.9 CBR Systems, Inc.
13.9.1 CBR Systems, Inc. Company Details
13.9.2 CBR Systems, Inc. Business Overview
13.9.3 CBR Systems, Inc. Cord Blood Stem Cells Introduction
13.9.4 CBR Systems, Inc. Revenue in Cord Blood Stem Cells Business (2015-2020)
13.9.5 CBR Systems, Inc. Recent Development
13.10 Cordlife
13.10.1 Cordlife Company Details
13.10.2 Cordlife Business Overview
13.10.3 Cordlife Cord Blood Stem Cells Introduction
13.10.4 Cordlife Revenue in Cord Blood Stem Cells Business (2015-2020)
13.10.5 Cordlife Recent Development
13.11 Cryo-Cell
10.11.1 Cryo-Cell Company Details
10.11.2 Cryo-Cell Business Overview
10.11.3 Cryo-Cell Cord Blood Stem Cells Introduction
10.11.4 Cryo-Cell Revenue in Cord Blood Stem Cells Business (2015-2020)
10.11.5 Cryo-Cell Recent Development
13.12 Cryo-Save AG (A Group of Esperite)
10.12.1 Cryo-Save AG (A Group of Esperite) Company Details
10.12.2 Cryo-Save AG (A Group of Esperite) Business Overview
10.12.3 Cryo-Save AG (A Group of Esperite) Cord Blood Stem Cells Introduction
10.12.4 Cryo-Save AG (A Group of Esperite) Revenue in Cord Blood Stem Cells Business (2015-2020)
10.12.5 Cryo-Save AG (A Group of Esperite) Recent Development
13.13 Lifecell
10.13.1 Lifecell Company Details
10.13.2 Lifecell Business Overview
10.13.3 Lifecell Cord Blood Stem Cells Introduction
10.13.4 Lifecell Revenue in Cord Blood Stem Cells Business (2015-2020)
10.13.5 Lifecell Recent Development
13.14 Stemcyte
10.14.1 Stemcyte Company Details
10.14.2 Stemcyte Business Overview
10.14.3 Stemcyte Cord Blood Stem Cells Introduction
10.14.4 Stemcyte Revenue in Cord Blood Stem Cells Business (2015-2020)
10.14.5 Stemcyte Recent Development
13.15 Viacord
10.15.1 Viacord Company Details
10.15.2 Viacord Business Overview
10.15.3 Viacord Cord Blood Stem Cells Introduction
10.15.4 Viacord Revenue in Cord Blood Stem Cells Business (2015-2020)
10.15.5 Viacord Recent Development
13.16 Smart Cells International Ltd.
10.16.1 Smart Cells International Ltd. Company Details
10.16.2 Smart Cells International Ltd. Business Overview
10.16.3 Smart Cells International Ltd. Cord Blood Stem Cells Introduction
10.16.4 Smart Cells International Ltd. Revenue in Cord Blood Stem Cells Business (2015-2020)
10.16.5 Smart Cells International Ltd. Recent Development
13.17 Cryoviva India
10.17.1 Cryoviva India Company Details
10.17.2 Cryoviva India Business Overview
10.17.3 Cryoviva India Cord Blood Stem Cells Introduction
10.17.4 Cryoviva India Revenue in Cord Blood Stem Cells Business (2015-2020)
10.17.5 Cryoviva India Recent Development
13.18 Cordvida
10.18.1 Cordvida Company Details
10.18.2 Cordvida Business Overview
10.18.3 Cordvida Cord Blood Stem Cells Introduction
10.18.4 Cordvida Revenue in Cord Blood Stem Cells Business (2015-2020)
10.18.5 Cordvida Recent Development
13.19 China Cord Blood Corporation
10.19.1 China Cord Blood Corporation Company Details
10.19.2 China Cord Blood Corporation Business Overview
10.19.3 China Cord Blood Corporation Cord Blood Stem Cells Introduction
10.19.4 China Cord Blood Corporation Revenue in Cord Blood Stem Cells Business (2015-2020)
10.19.5 China Cord Blood Corporation Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Cord Blood Stem Cells Key Market Segments
Table 2. Key Players Covered: Ranking by Cord Blood Stem Cells Revenue
Table 3. Ranking of Global Top Cord Blood Stem Cells Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cord Blood Stem Cells Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Allogeneic Stem Cell
Table 6. Key Players of Autologous Stem Cell
Table 7. Global Cord Blood Stem Cells Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Cord Blood Stem Cells Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Cord Blood Stem Cells Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Cord Blood Stem Cells Market Share by Regions (2015-2020)
Table 11. Global Cord Blood Stem Cells Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Cord Blood Stem Cells Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Cord Blood Stem Cells Market Growth Strategy
Table 17. Main Points Interviewed from Key Cord Blood Stem Cells Players
Table 18. Global Cord Blood Stem Cells Revenue by Players (2015-2020) (Million US$)
Table 19. Global Cord Blood Stem Cells Market Share by Players (2015-2020)
Table 20. Global Top Cord Blood Stem Cells Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cord Blood Stem Cells as of 2019)
Table 21. Global Cord Blood Stem Cells by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Cord Blood Stem Cells Product Solution and Service
Table 24. Date of Enter into Cord Blood Stem Cells Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cord Blood Stem Cells Market Size by Type (2015-2020) (Million US$)
Table 27. Global Cord Blood Stem Cells Market Size Share by Type (2015-2020)
Table 28. Global Cord Blood Stem Cells Revenue Market Share by Type (2021-2026)
Table 29. Global Cord Blood Stem Cells Market Size Share by Application (2015-2020)
Table 30. Global Cord Blood Stem Cells Market Size by Application (2015-2020) (Million US$)
Table 31. Global Cord Blood Stem Cells Market Size Share by Application (2021-2026)
Table 32. North America Key Players Cord Blood Stem Cells Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Cord Blood Stem Cells Market Share (2019-2020)
Table 34. North America Cord Blood Stem Cells Market Size by Type (2015-2020) (Million US$)
Table 35. North America Cord Blood Stem Cells Market Share by Type (2015-2020)
Table 36. North America Cord Blood Stem Cells Market Size by Application (2015-2020) (Million US$)
Table 37. North America Cord Blood Stem Cells Market Share by Application (2015-2020)
Table 38. Europe Key Players Cord Blood Stem Cells Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Cord Blood Stem Cells Market Share (2019-2020)
Table 40. Europe Cord Blood Stem Cells Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Cord Blood Stem Cells Market Share by Type (2015-2020)
Table 42. Europe Cord Blood Stem Cells Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Cord Blood Stem Cells Market Share by Application (2015-2020)
Table 44. China Key Players Cord Blood Stem Cells Revenue (2019-2020) (Million US$)
Table 45. China Key Players Cord Blood Stem Cells Market Share (2019-2020)
Table 46. China Cord Blood Stem Cells Market Size by Type (2015-2020) (Million US$)
Table 47. China Cord Blood Stem Cells Market Share by Type (2015-2020)
Table 48. China Cord Blood Stem Cells Market Size by Application (2015-2020) (Million US$)
Table 49. China Cord Blood Stem Cells Market Share by Application (2015-2020)
Table 50. Japan Key Players Cord Blood Stem Cells Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Cord Blood Stem Cells Market Share (2019-2020)
Table 52. Japan Cord Blood Stem Cells Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Cord Blood Stem Cells Market Share by Type (2015-2020)
Table 54. Japan Cord Blood Stem Cells Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Cord Blood Stem Cells Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Cord Blood Stem Cells Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Cord Blood Stem Cells Market Share (2019-2020)
Table 58. Southeast Asia Cord Blood Stem Cells Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Cord Blood Stem Cells Market Share by Type (2015-2020)
Table 60. Southeast Asia Cord Blood Stem Cells Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Cord Blood Stem Cells Market Share by Application (2015-2020)
Table 62. India Key Players Cord Blood Stem Cells Revenue (2019-2020) (Million US$)
Table 63. India Key Players Cord Blood Stem Cells Market Share (2019-2020)
Table 64. India Cord Blood Stem Cells Market Size by Type (2015-2020) (Million US$)
Table 65. India Cord Blood Stem Cells Market Share by Type (2015-2020)
Table 66. India Cord Blood Stem Cells Market Size by Application (2015-2020) (Million US$)
Table 67. India Cord Blood Stem Cells Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Cord Blood Stem Cells Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Cord Blood Stem Cells Market Share (2019-2020)
Table 70. Central & South America Cord Blood Stem Cells Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Cord Blood Stem Cells Market Share by Type (2015-2020)
Table 72. Central & South America Cord Blood Stem Cells Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Cord Blood Stem Cells Market Share by Application (2015-2020)
Table 74. Advanced Cell Technology Company Details
Table 75. Advanced Cell Technology Business Overview
Table 76. Advanced Cell Technology Product
Table 77. Advanced Cell Technology Revenue in Cord Blood Stem Cells Business (2015-2020) (Million US$)
Table 78. Advanced Cell Technology Recent Development
Table 79. California Stem Cell Company Details
Table 80. California Stem Cell Business Overview
Table 81. California Stem Cell Product
Table 82. California Stem Cell Revenue in Cord Blood Stem Cells Business (2015-2020) (Million US$)
Table 83. California Stem Cell Recent Development
Table 84. Cytori Therapeutics Company Details
Table 85. Cytori Therapeutics Business Overview
Table 86. Cytori Therapeutics Product
Table 87. Cytori Therapeutics Revenue in Cord Blood Stem Cells Business (2015-2020) (Million US$)
Table 88. Cytori Therapeutics Recent Development
Table 89. Mesoblast Limited Company Details
Table 90. Mesoblast Limited Business Overview
Table 91. Mesoblast Limited Product
Table 92. Mesoblast Limited Revenue in Cord Blood Stem Cells Business (2015-2020) (Million US$)
Table 93. Mesoblast Limited Recent Development
Table 94. Opexa Therapeutics Inc. Company Details
Table 95. Opexa Therapeutics Inc. Business Overview
Table 96. Opexa Therapeutics Inc. Product
Table 97. Opexa Therapeutics Inc. Revenue in Cord Blood Stem Cells Business (2015-2020) (Million US$)
Table 98. Opexa Therapeutics Inc. Recent Development
Table 99. Athersys Inc. Company Details
Table 100. Athersys Inc. Business Overview
Table 101. Athersys Inc. Product
Table 102. Athersys Inc. Revenue in Cord Blood Stem Cells Business (2015-2020) (Million US$)
Table 103. Athersys Inc. Recent Development
Table 104. Geron Corporation Company Details
Table 105. Geron Corporation Business Overview
Table 106. Geron Corporation Product
Table 107. Geron Corporation Revenue in Cord Blood Stem Cells Business (2015-2020) (Million US$)
Table 108. Geron Corporation Recent Development
Table 109. Neostem Inc. Business Overview
Table 110. Neostem Inc. Product
Table 111. Neostem Inc. Company Details
Table 112. Neostem Inc. Revenue in Cord Blood Stem Cells Business (2015-2020) (Million US$)
Table 113. Neostem Inc. Recent Development
Table 114. CBR Systems, Inc. Company Details
Table 115. CBR Systems, Inc. Business Overview
Table 116. CBR Systems, Inc. Product
Table 117. CBR Systems, Inc. Revenue in Cord Blood Stem Cells Business (2015-2020) (Million US$)
Table 118. CBR Systems, Inc. Recent Development
Table 119. Cordlife Company Details
Table 120. Cordlife Business Overview
Table 121. Cordlife Product
Table 122. Cordlife Revenue in Cord Blood Stem Cells Business (2015-2020) (Million US$)
Table 123. Cordlife Recent Development
Table 124. Cryo-Cell Company Details
Table 125. Cryo-Cell Business Overview
Table 126. Cryo-Cell Product
Table 127. Cryo-Cell Revenue in Cord Blood Stem Cells Business (2015-2020) (Million US$)
Table 128. Cryo-Cell Recent Development
Table 129. Cryo-Save AG (A Group of Esperite) Company Details
Table 130. Cryo-Save AG (A Group of Esperite) Business Overview
Table 131. Cryo-Save AG (A Group of Esperite) Product
Table 132. Cryo-Save AG (A Group of Esperite) Revenue in Cord Blood Stem Cells Business (2015-2020) (Million US$)
Table 133. Cryo-Save AG (A Group of Esperite) Recent Development
Table 134. Lifecell Company Details
Table 135. Lifecell Business Overview
Table 136. Lifecell Product
Table 137. Lifecell Revenue in Cord Blood Stem Cells Business (2015-2020) (Million US$)
Table 138. Lifecell Recent Development
Table 139. Stemcyte Company Details
Table 140. Stemcyte Business Overview
Table 141. Stemcyte Product
Table 142. Stemcyte Revenue in Cord Blood Stem Cells Business (2015-2020) (Million US$)
Table 143. Stemcyte Recent Development
Table 144. Viacord Company Details
Table 145. Viacord Business Overview
Table 146. Viacord Product
Table 147. Viacord Revenue in Cord Blood Stem Cells Business (2015-2020) (Million US$)
Table 148. Viacord Recent Development
Table 149. Smart Cells International Ltd. Company Details
Table 150. Smart Cells International Ltd. Business Overview
Table 151. Smart Cells International Ltd. Product
Table 152. Smart Cells International Ltd. Revenue in Cord Blood Stem Cells Business (2015-2020) (Million US$)
Table 153. Smart Cells International Ltd. Recent Development
Table 154. Cryoviva India Company Details
Table 155. Cryoviva India Business Overview
Table 156. Cryoviva India Product
Table 157. Cryoviva India Revenue in Cord Blood Stem Cells Business (2015-2020) (Million US$)
Table 158. Cryoviva India Recent Development
Table 159. Cordvida Company Details
Table 160. Cordvida Business Overview
Table 161. Cordvida Product
Table 162. Cordvida Revenue in Cord Blood Stem Cells Business (2015-2020) (Million US$)
Table 163. Cordvida Recent Development
Table 164. China Cord Blood Corporation Company Details
Table 165. China Cord Blood Corporation Business Overview
Table 166. China Cord Blood Corporation Product
Table 167. China Cord Blood Corporation Revenue in Cord Blood Stem Cells Business (2015-2020) (Million US$)
Table 168. China Cord Blood Corporation Recent Development
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cord Blood Stem Cells Market Share by Type: 2020 VS 2026
Figure 2. Allogeneic Stem Cell Features
Figure 3. Autologous Stem Cell Features
Figure 4. Global Cord Blood Stem Cells Market Share by Application: 2020 VS 2026
Figure 5. Autoimmune Diseases Case Studies
Figure 6. Immunodeficiencies Case Studies
Figure 7. Malignancies,Caners Case Studies
Figure 8. Solid Tumors Case Studies
Figure 9. Others Case Studies
Figure 10. Cord Blood Stem Cells Report Years Considered
Figure 11. Global Cord Blood Stem Cells Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Cord Blood Stem Cells Market Share by Regions: 2020 VS 2026
Figure 13. Global Cord Blood Stem Cells Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Cord Blood Stem Cells Market Share by Players in 2019
Figure 16. Global Top Cord Blood Stem Cells Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cord Blood Stem Cells as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Cord Blood Stem Cells Revenue in 2019
Figure 18. North America Cord Blood Stem Cells Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Cord Blood Stem Cells Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Cord Blood Stem Cells Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Cord Blood Stem Cells Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Cord Blood Stem Cells Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Cord Blood Stem Cells Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Cord Blood Stem Cells Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
自家幹細胞ベース治療法の世界市場（～2026年） Market Analysis and Insights: Global Autologous Stem Cell Based Therapies Market The global Autologous Stem Cell Based Therapies market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Autologous Stem Cell Based Therapies Scop…- ヒト間葉系幹細胞（hMSC）の世界市場（～2026年） Human mesenchymal stem cells (hMSC) are multipotent stromal cells that can differentiate into a variety of cell types. Market Analysis and Insights: Global Human Mesenchymal Stem Cells (hMSC) Market The global Human Mesenchymal Stem Cells (hMSC) market size is projected to reach US$ XX million by 20…
- 循環腫瘍細胞（CTC）＆がん幹細胞の世界市場（～2026年） The tumor cells which have shed into lymphatic system and circulated over the body through blood circulation are called as circulating tumor cells. Circulating tumor cells may comprise seeds for metastasis. Stem cells are the type of cells that can differentiate into specialized cells and have the c…
- 犬幹細胞治療の世界市場（～2026年） The non-invasive stem cell obtaining procedure, augmented possibility of accomplishing high quality cells, and lower price of therapy coupled with high success rate of positive outcomes have collectively made allogeneic stem cell therapy a preference for veterinary physicians. Moreover, allogeneic s…
- がん幹細胞治療の世界市場（～2026年） Market Analysis and Insights: Global Cancer Stem Cell Therapy Market The global Cancer Stem Cell Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cancer Stem Cell Therapy Scope and Market Size Cancer Stem Cell T…